Pancreatic Vaccine: Frequently Asked Questions

Is the Johns Hopkins pancreatic cancer vaccine available now?

The experimental pancreatic cancer vaccine is being tested in clinical trials only at this point and is not available outside of these clinical trials. Patients who were on previous studies may continue to receive vaccine booster shots.

When will the next study begin? Can I put my name on the list?

We are unable to keep a list of individuals interested in the vaccine, but we are always working on new studies utilizing the pancreatic vaccine and we recommend you check back with us for updates on the clinical trials section of our Web site.

Are there any other pancreatic cancer clinical trials available now at Johns Hopkins?

Yes. We are conducting a study for patients who can undergo surgery. The vaccine is given first and then surgery is performed two weeks later.  We are also conducting a study for patients who are within 18 months of their Whipple surgery and are cancer free.

Will I be able to find out if I'm eligible for a clinical trial over the phone?

No. Eligibility is determined after patients have been examined in person by our team of pancreatic cancer experts. Appointments can be made by calling our New Patient Appointment department: 410-955-8964 (choose option 2 when prompted).

Are there other therapies that might be helpful to me?

Johns Hopkins pancreatic cancer experts can discuss a variety of treatment options available, including other clinical trials that do not include the vaccine. Please call our New Patient Appointment department at 410-955-8964 (choose option 2 when prompted) to schedule a consultation with our experts.